Comment on CMS-2026-1255-0001

Summary: Sanofi, a biopharmaceutical company, supports CMS's proposal to modernize and standardize the prior authorization process for prescription drugs to improve patient access and reduce administrative burdens. They advocate for specific improvements, including 24-hour decision timeframes, transparency regarding AI use in determinations, and protections for patients with rare or chronic diseases to ensure continuity of care.